Form 4 for SLS SELLAS Life Sciences Group, Inc.
Accepted 2025-05-22 00:00:00 ET · period of report 2025-05-22 · accession 0001104659-25-051980 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-22 | 2025-05-22 | SLS | Kalin Katherine Bach | Dir | P - Purchase | $1.80 | +20.0K | 41.0K | +95% | +$36.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-22 | P | A | 20,000 | $1.80 | 41,000 | D | — | — |